3500-US-2500149 04/25

© 2025 MyoKardia, Inc., a Bristol Myers Squibb company.
CAMZYOS® and the CAMZYOS and MyCAMZYOS Logos are trademarks of MyoKardia, Inc.
This website is intended for U.S. residents 18 years of age or older.
3500-US-2400785 03/25

Cammie
Are you sure you want to end the conversation?
I haven't heard from you in a while. Is there anything else I can help you with today?
To begin with, there are a few things I need to tell you. Please use the scroll bar on the upper right to view all of the information and then press continue. All conversations are recorded for quality purposes. Support is available for customers in the U.S. The information you provide will be governed by our privacy policy. I cannot provide medical advice. Your healthcare provider is the best source of medical information. Some important safety information to know is: CAMZYOS® (mavacamten) may cause serious side effects, including heart failure, a condition where the heart cannot pump with enough force. Heart failure is a serious condition that can lead to death. You must have echocardiograms before you take your first dose and during your treatment with CAMZYOS to help your healthcare provider understand how your heart is responding to CAMZYOS. People who develop a serious infection or irregular heartbeat have a greater risk of heart failure during treatment with CAMZYOS. Tell your healthcare provider or get medical help right away if you develop new or worsening shortness of breath, chest pain, fatigue, swelling in your legs, or a racing sensation in your heart (palpitations) or rapid weight gain. Please click here for full Important Safety Information, including Boxed WARNING, for CAMZYOS.
Please see the full U.S. Prescribing Information, including Boxed WARNING, and the Medication Guide for CAMZYOS. For your privacy protection, please do not share personal information about another person.
Continue